Epidemiological Study to Describe Non Small Cell Lung Cancer (NSCLC) Clinical Management Patterns in Central Eastern Europe and Russia (Lung-EPICLIN)
NCT01069835 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 840
Last updated 2015-05-19
Summary
The overall aim of the study is:
To provide accurate and reliable information regarding NSCLC clinical management across Central Eastern European countries and Russia in order to detect unmet medical needs of this disease in terms of:
* Patient and hospital characteristics.
* Diagnostic and treatment approaches: initial and subsequent.
* Follow-up patterns in clinical management.
* Outcomes: symptoms, death, functionality, quality of life.
* Use of resources and burden on patients and health care systems. Addendum objective is to collect epidemiological data on EGFR mutation status (M+, M-) in the Russian population
Conditions
- Non Small Cell Lung Cancer
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-02-28
- Primary Completion
- 2011-03-31
- Completion
- 2012-03-31
Countries
- Russia
Study Locations
More Related Trials
-
Study for Patients With Non Small Cell Lung Cancer (NSCLC)
NCT00168883 ·Status: UNKNOWN ·Phase: PHASE2
-
Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments
NCT06448793 ·Status: RECRUITING
-
Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide
NCT00290953 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients
NCT00044538 ·Status: COMPLETED ·Phase: PHASE2
-
Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC)
NCT01368848 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical Practice
NCT01893268 ·Status: COMPLETED
-
Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer
NCT01493843 ·Status: COMPLETED ·Phase: PHASE2
-
Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer
NCT00622349 ·Status: COMPLETED ·Phase: PHASE3
-
LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy
NCT00328588 ·Status: COMPLETED ·Phase: PHASE2
-
National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer
NCT02664935 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Study of CRLX101(NLG207) in Patients With Advanced Non-Small Cell Lung Cancer
NCT01380769 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations
NCT02109016 ·Status: TERMINATED ·Phase: PHASE2
-
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
NCT02154490 ·Status: COMPLETED
-
Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung Metastasis
NCT01014598 ·Status: COMPLETED ·Phase: PHASE1
-
An Open Label Study in Patients With Advanced NSCLC With ABI-007(Abraxane) in Combination With Carboplatin
NCT00274443 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
NCT01297491 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy in Treating Patients With Lung Cancer
NCT01067794 ·Status: COMPLETED
-
Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer
NCT00064350 ·Status: COMPLETED ·Phase: PHASE2
-
A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage
NCT00168896 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC
NCT02852083 ·Status: UNKNOWN ·Phase: PHASE2
-
Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer)
NCT03053297 ·Status: TERMINATED
-
Paclitaxel in Treating Patients With Lung Cancer
NCT00002972 ·Status: COMPLETED ·Phase: PHASE2
-
Study for Therapy of Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) With Cisplatin / Docetaxel or Oxaliplatin / Docetaxel
NCT01222312 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer
NCT02470468 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC
NCT05468489 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3